News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
860,816 Results
Type
Article (87423)
Company Profile (760)
Press Release (772611)
Multimedia
Podcasts (172)
Webinars (28)
Section
Business (233052)
Career Advice (4139)
Deals (39795)
Drug Delivery (136)
Drug Development (91247)
Employer Resources (203)
FDA (18280)
Job Trends (17399)
News (397382)
Policy (39926)
Tag
Academia (3005)
Academic (2)
Accelerated approval (18)
Adcomms (35)
Allergies (124)
Alliances (56979)
ALS (145)
Alzheimer's disease (1680)
Antibody-drug conjugate (ADC) (243)
Approvals (18300)
Artificial intelligence (487)
Autoimmune disease (73)
Automation (25)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (159)
Biotechnology (484)
Bladder cancer (129)
Brain cancer (52)
Breast cancer (500)
Cancer (3932)
Cardiovascular disease (338)
Career advice (3556)
Career pathing (38)
CAR-T (246)
CDC (57)
Cell therapy (682)
Cervical cancer (33)
Clinical research (75477)
Collaboration (1380)
Company closure (4)
Compensation (938)
Complete response letters (59)
COVID-19 (2956)
CRISPR (81)
C-suite (587)
Cystic fibrosis (135)
Data (4434)
Decentralized trials (2)
Denatured (61)
Depression (110)
Diabetes (452)
Diagnostics (7091)
Digital health (36)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (230)
Drug pricing (190)
Drug shortages (36)
Duchenne muscular dystrophy (203)
Earnings (98792)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (132959)
Executive appointments (988)
FDA (20732)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (6)
Frontotemporal dementia (14)
Funding (1251)
Gene editing (173)
Generative AI (48)
Gene therapy (545)
GLP-1 (1019)
Government (5384)
Grass and pollen (7)
Guidances (340)
Healthcare (20937)
HIV (48)
Huntington's disease (37)
IgA nephropathy (62)
Immunology and inflammation (241)
Immuno-oncology (20)
Indications (53)
Infectious disease (3192)
Inflammatory bowel disease (186)
Inflation Reduction Act (15)
Influenza (96)
Intellectual property (187)
Interviews (815)
IPO (17926)
IRA (59)
Job creations (5197)
Job search strategy (2865)
Kidney cancer (16)
Labor market (77)
Layoffs (640)
Leadership (33)
Legal (10148)
Liver cancer (91)
Longevity (12)
Lung cancer (564)
Lymphoma (265)
Machine learning (30)
Management (66)
Manufacturing (635)
MASH (138)
Medical device (14869)
Medtech (14892)
Mergers & acquisitions (22743)
Metabolic disorders (1151)
Multiple sclerosis (137)
NASH (23)
Neurodegenerative disease (227)
Neuropsychiatric disorders (60)
Neuroscience (2711)
NextGen: Class of 2025 (7687)
Non-profit (5096)
Now hiring (57)
Obesity (556)
Opinion (312)
Ovarian cancer (133)
Pain (165)
Pancreatic cancer (171)
Parkinson's disease (242)
Partnered (30)
Patents (416)
Patient recruitment (310)
Peanut (57)
People (66252)
Pharmaceutical (144)
Pharmacy benefit managers (27)
Phase I (23279)
Phase II (32762)
Phase III (24679)
Pipeline (2711)
Policy (295)
Postmarket research (3554)
Preclinical (10496)
Press Release (72)
Prostate cancer (200)
Psychedelics (52)
Radiopharmaceuticals (282)
Rare diseases (670)
Real estate (7421)
Recruiting (78)
Regulatory (27999)
Reports (65)
Research institute (2688)
Resumes & cover letters (651)
Rett syndrome (16)
RNA editing (15)
RSV (70)
Schizophrenia (135)
Series A (207)
Series B (156)
Service/supplier (30)
Sickle cell disease (79)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4318)
State (2)
Stomach cancer (17)
Supply chain (100)
Tariffs (95)
The Weekly (109)
Vaccines (1043)
Venture capital (66)
Weight loss (395)
Women's health (58)
Worklife (21)
Date
Today (141)
Last 7 days (690)
Last 30 days (2407)
Last 365 days (33494)
2025 (26352)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1279)
Alabama (80)
Alaska (7)
Arizona (302)
Arkansas (14)
Asia (50969)
Australia (8956)
California (9422)
Canada (2855)
China (896)
Colorado (400)
Connecticut (422)
Delaware (270)
Europe (117092)
Florida (1390)
Georgia (315)
Hawaii (3)
Idaho (67)
Illinois (811)
India (51)
Indiana (460)
Iowa (19)
Japan (323)
Kansas (124)
Kentucky (38)
Louisiana (20)
Maine (77)
Maryland (1275)
Massachusetts (7107)
Michigan (313)
Minnesota (563)
Mississippi (4)
Missouri (119)
Montana (33)
Nebraska (26)
Nevada (107)
New Hampshire (77)
New Jersey (2620)
New Mexico (32)
New York (2570)
North Carolina (1410)
North Dakota (10)
Northern California (4255)
Ohio (295)
Oklahoma (22)
Oregon (50)
Pennsylvania (1963)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (49)
South Dakota (1)
Southern California (3602)
Tennessee (149)
Texas (1475)
United States (34891)
Utah (282)
Virginia (248)
Washington D.C. (83)
Washington State (817)
West Virginia (4)
Wisconsin (97)
Wyoming (1)
There are 860,816 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Chiesi Global Rare Diseases and Protalix Biotherapeutics Acknowledge CHMP Negative Opinion on Every Four Week Dosing Regimen of Elfabrio® (pegunigalsidase alfa) in the EU
October 20, 2025
·
11 min read
Press Releases
Novartis Scemblix® receives positive CHMP opinion for the treatment of adults with newly diagnosed CML
October 20, 2025
·
12 min read
Press Releases
CHMP recommends EU approval of Roche’s Gazyva/Gazyvaro for lupus nephritis
October 20, 2025
·
8 min read
Press Releases
Press Release: Sanofi’s Wayrilz recommended for EU approval by the CHMP to treat immune thrombocytopenia
October 20, 2025
·
7 min read
Press Releases
Press Release: Sanofi provides update on regulatory review in the EU for Rezurock to treat chronic graft-vs-host disease
October 20, 2025
·
6 min read
Press Releases
Climb Bio to Present Data at American Society of Nephrology (ASN) Kidney Week 2025
October 20, 2025
·
7 min read
Press Releases
Eledon Pharmaceuticals to Present Results from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology Kidney Week 2025 Annual Meeting
October 20, 2025
·
2 min read
Press Releases
Tonix Pharmaceuticals Presented Data on TNX-801 Mpox Vaccine at World Vaccine Congress–Europe 2025
October 20, 2025
·
13 min read
Press Releases
XORTX Announces Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems
October 20, 2025
·
6 min read
Press Releases
Sight Sciences Announces Fee Schedule Establishment from Novitas Solutions and First Coast Service Options for the TearCare® Interventional Dry Eye Procedure
October 20, 2025
·
6 min read
1 of 86,082
Next
